BioCryst Pharmaceuticals (NASDAQ:BCRX) Anticipates to Improve its revenue - TSLA, KWK
Northern, WI 04/02/2013 (avauncer) - BioCryst Pharmaceuticals (NASDAQ:BCRX), with a one year target of 2, (current $1.34, down by 2.90%). While the share volume increased to 3,531,597, the price of the shares remained much lower than its 52 week record high of $5.14....
Posted On 02 Apr 2013